Rogier M Klok

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. doi request reprint Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden
    Rogier M Klok
    Pfizer bv, Capelle a d Ijssel, The Netherlands
    Clin Ther 35:119-34. 2013

Collaborators

Detail Information

Publications1

  1. doi request reprint Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden
    Rogier M Klok
    Pfizer bv, Capelle a d Ijssel, The Netherlands
    Clin Ther 35:119-34. 2013
    ..Two new PCVs have been launched, a 10-valent pneumococcal conjugate vaccine (PCV10) and a 13-valent pneumococcal conjugate vaccine (PCV13)...